To have a drug that has an impact on mortality, it’s of huge interest and a benefit for patients with ILD,’ said rheumatologist Voon Ong, MBBS, PhD, who was not involved in the study.

Cases of a deadly lung disease have been reported this week among guests at a luxury Las Vegas hotel.

November is National Chronic Obstructive Pulmonary Disease Awareness Month. It’s time to raise awareness about lung disease within our communities. By understanding the causes, reducing our risk ...

Anxiety and depression are prevalent in patients with IPF and are linked to increased breathlessness and lower energy levels.

Arizona author and journalist Terry Green Sterling has non-tuberculous mycobacterial pulmonary disease — an ailment that's ...

Chronic obstructive pulmonary disease (COPD) remains a substantial contributor to morbidity and mortality in the United States with an estimated 3.8% age-adjusted prevalence and 141,733 COPD deaths ...

Don't ignore the subtle changes in your stamina; persistent coughs and shortness of breath could be more than just signs of ...

United Therapeutics is making headway in unlocking a new lung disease market for its drug Tyvaso (treprostinil) with a pivotal phase 3 win in idiopathic pulmonary fibrosis (IPF). United’s Teton-2 ...

A new study by researchers at National Jewish Health and collaborating institutions has found that different patterns seen on ...

While sex is commonly disclosed in interstitial lung disease trials, data on participant race and ethnicity are infrequently documented.

It's a very conflicting feeling to be feeling better than you have in a decade and hearing that it came at the price of a ...